Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.0 is now active, replacing v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check73 days agoChange DetectedA government funding status notice banner was added and the page revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedMinor UI and metadata updates were made, including adding a glossary toggle and new labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while related items like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.